Neuroendocrine tumours in the context of personalised medicine: Critical challenges

Speaker: Nicola Fazio

Nicola Fazio provides overview of the current classifications and clinical implications of neuroendocrine tumours (NETs), the role of somatostatin receptor, what is current practice and treatment of advanced GEP and lung NETs, the key prognostic and predictive factors in NETs, as well as current challenges and future perspectives in the research and treatment of NETs.

Discussion Points

  • Neuroendocrine tumours: Current classifications and clinical implications
  • Role of somatostatin receptors in the diagnosis and treatment of neuroendocrine tumours 
  • Medical treatment of advanced GEP and LUNG NET
  • Prognostic and predictive factors in neuroendocrine tumours
  • Current challenges and future perspective in the research and treatment of neuroendocrine tumours